Publications en collaboration avec des chercheurs de Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (24)

2024

  1. Interferon and B-cell Signatures Inform Precision Medicine in Lupus Nephritis

    Kidney International Reports, Vol. 9, Núm. 6, pp. 1817-1835

  2. Molecular characterisation of lupus low disease activity state (LLDAS) and DORIS remission by whole-blood transcriptome-based pathways in a pan-European systemic lupus erythematosus cohort

    Annals of the Rheumatic Diseases, Vol. 83, Núm. 7, pp. 889-900

  3. Molecular subtypes explain lupus epigenomic heterogeneity unveiling new regulatory genetic risk variants

    npj Genomic Medicine, Vol. 9, Núm. 1

2023

  1. Corrigendum to ‘Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus’ [J. Autoimmun. 136 (April 2023) 103025] (Journal of Autoimmunity (2023) 136, (S0896841123000343), (10.1016/j.jaut.2023.103025))

    Journal of Autoimmunity

  2. Distinct gene dysregulation patterns herald precision medicine potentiality in systemic lupus erythematosus

    Journal of Autoimmunity, Vol. 136

  3. Erratum to: Mapping the human genetic architecture of COVID-19 (Nature, (2021), 600, 7889, (472-477), 10.1038/s41586-021-03767-x)

    Nature

  4. Serum profiling identifies CCL8, CXCL13, and IL-1RA as markers of active disease in patients with systemic lupus erythematosus

    Frontiers in Immunology, Vol. 14

2022

  1. Complement component C4 structural variation and quantitative traits contribute to sex-biased vulnerability in systemic sclerosis

    npj Genomic Medicine, Vol. 7, Núm. 1

  2. Novel genes and sex differences in COVID-19 severity

    Human molecular genetics, Vol. 31, Núm. 22, pp. 3789-3806

2021

  1. A new molecular classification to drive precision treatment strategies in primary Sjögren’s syndrome

    Nature Communications, Vol. 12, Núm. 1

  2. Age-dependent impact of the major common genetic risk factor for COVID-19 on severity and mortality

    Journal of Clinical Investigation, Vol. 131, Núm. 23

  3. Expression Quantitative Trait Locus Analysis in Systemic Sclerosis Identifies New Candidate Genes Associated With Multiple Aspects of Disease Pathology

    Arthritis & rheumatology (Hoboken, N.J.), Vol. 73, Núm. 7, pp. 1288-1300

  4. Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases

    Arthritis and Rheumatology, Vol. 73, Núm. 6, pp. 1073-1085

  5. Integrative epigenomics in Sjögren´s syndrome reveals novel pathways and a strong interaction between the HLA, autoantibodies and the interferon signature

    Scientific Reports, Vol. 11, Núm. 1

  6. Mapping the human genetic architecture of COVID-19

    Nature, Vol. 600, Núm. 7889, pp. 472-477

2020

  1. Discovering new metabolite alterations in primary sjögren's syndrome in urinary and plasma samples using an HPLC-ESI-QTOF-MS methodology

    Journal of Pharmaceutical and Biomedical Analysis, Vol. 179

  2. Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients

    Annals of the Rheumatic Diseases, Vol. 79, Núm. 9, pp. 1218-1226

  3. IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases

    Scientific Reports, Vol. 10, Núm. 1

  4. Standardization procedure for flow cytometry data harmonization in prospective multicenter studies

    Scientific Reports, Vol. 10, Núm. 1

2019

  1. Identification of a shared microbiomic and metabolomic profile in systemic autoimmune diseases

    Journal of Clinical Medicine, Vol. 8, Núm. 9